Candel ($CADL) is a clinical stage biopharmaceutical company focused on developing off-the-shelf multimodal biological immunotherapies that elicit an individualized, systemic anti-tumor immune response to help patients fight cancer. Candel has established two clinical stage multimodal biological immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) gene constructs, respectively. CAN-3110 is the lead product candidate from the HSV platform and is currently in an ongoing investigator-sponsored phase 1 clinical trial in recurrent high-grade glioma (HGG). In addition, Candel’s enLIGHTEN™ Discovery Platform is a systematic, iterative HSV-based discovery platform leveraging human biology and advanced analytics to create new viral immunotherapies for solid tumors. CAN-2409 is the lead product candidate from the adenovirus platform and is currently in ongoing clinical trials in non-small cell lung cancer (NSCLC) (phase 2), borderline resectable pancreatic cancer (phase 2), and localized, non-metastatic prostate cancer (phase 2 and phase 3). For more information, visit www.candeltx.com or contact us at info@candeltx.com.
Company Details
- Employees
- 69
- Founded
- -
- Address
- 117 Kendrick Street,
- Phone
- 6179165445
- in****@****ltx.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- candeltx.com
- Keywords
- Immuno-oncology, Oncology, Viral Immunotherapy, Prostate Cancer, Brain Cancer, Biotechnology.
- HQ
- Needham, Massachusetts
Candel Therapeutics Questions
Candel Therapeutics's helpline number is 6179165445
Candel Therapeutics's website is candeltx.com
Candel Therapeutics's LinkedIn profile is https://www.linkedin.com/company/candel-therapeutics
Candel Therapeutics has
69 employees.
View email and phone details for 69
employees at Candel Therapeutics.
Candel Therapeutics's industry is
Biotechnology Research
Candel Therapeutics's top competitors are
Sitryx,
Elicio Therapeutics,
Ladrx Corporation,
Newamsterdam Pharma Corporation,
Citryll,
Chimerix, A Jazz Pharmaceuticals Company,
Beam Therapeutics,
Nimble Therapeutics,
Keros Therapeutics,
Vertex Pharmaceuticals.
Candel Therapeutics's support email address is info@candeltx.com
Candel Therapeutics's categories are Biotechnology Research
Candel Therapeutics's founding year is 1999
